The OmniTom Elite within the SmartMSU is user-friendly, small in size and delivers high-quality 16-slice CT images including angiography and perfusion head scans.
News | Stroke
NeuroLogica Installs Next-Generation SmartMSU with OmniTom Elite in the Asia-Pacific Region

December 30, 2022 — NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced the first installation of ...

Home December 30, 2022
Home
Screen Shot 2022-12-29 at 7.21.22 PM_1
News | Congenital Heart
Smidt Heart Institute at Cedars-Sinai Welcomes Four New Specialists to Department of Cardiology

December 30, 2022 — The Smidt Heart Institute at Cedars-Sinai welcomes four new specialists to its Department of ...

Home December 30, 2022
Home
Dr. Alexander Shestopalov, MD
News | Peripheral Artery Disease (PAD)
Modern Vascular and Local Interventional Radiologist Pair Up To Reduce Unnecessary Amputations in Houston, Texas

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease ...

Home December 29, 2022
Home
Protein could yield potential therapeutic strategy to detect and prevent cancer therapy-associated heart failure
News | Heart Failure
Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

Home December 29, 2022
Home
Joanna Chikwe, MD
News | Heart Valve Technology
Cedars-Sinai Designated as Mitral Valve Repair Reference Center

December 29, 2022 — The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a ...

Home December 29, 2022
Home
Impella ECP, the world's smallest heart pump, is placed percutaneously into the heart's left ventricle. (Graphic: Business Wire)
News | Cardiovascular Clinical Studies
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

December 28 2022 — Abiomed announces the United States Food and Drug Administration (FDA) has approved the version of ...

Home December 28, 2022
Home
Keyur Vora, MD, MS, George Revtyak, MD, and Rohan Dharmakumar, PhD with the first patient to enroll in a new cardiovascular clinical trial.
News | Cardiovascular Clinical Studies
First Patient Enrolls in IU-led Clinical Trial to Study Treatment for Acute Heart Attack Complications

December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients ...

Home December 27, 2022
Home
Photo by: Congressman Andy Barr
News | Cardiovascular Business
CAROL Act to Expand Research Funding, Raise Awareness for Valvular Heart Disease

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy ...

Home December 27, 2022
Home
Two-day educational symposium was held in New York City at the NBPA’s headquarters 
News | Cardiovascular Education
Morristown Medical Center’s Matthew Martinez, MD Held First Sports Cardiology Summit for Elite and Professional Athletes

December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows ...

Home December 26, 2022
Home
Limited Exclusion Order would bar Apple from importing infringing Apple Watches 
News | ECG
ITC Rules Apple Violated AliveCor’s Patents

December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...

Home December 26, 2022
Home
Happy Holidays from DAIC
News | Diagnostic and Interventional Cardiology DAIC
Happy Holidays from DAIC

December 25, 2022 — The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and ...

Home December 25, 2022
Home
According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be valued at $2,897.2 million in 2022 and is expected to exhibit a CAGR of 6.6 % during the forecast period (2022-2030).
News | Stents Drug Eluting
Global Drug Eluting Stents Market to Surpass US$ 4,844.6 Million by 2030, Says Coherent Market Insights

December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...

Home December 23, 2022
Home
The first of its kind study involved 60 patients and confirmed Electroducer Sleeve as a safe and effective treatment for heart diseases
News | Guidewires
Electroducer announces the publication of positive results from its pilot study in EuroIntervention medical journal

December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment ...

Home December 23, 2022
Home
Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.
News | Cardiovascular Business
Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...

Home December 22, 2022
Home
Individuals with coronary artery disease exist on a spectrum of disease, such as the amount of plaque build-up in the arteries of the heart; however, the disease is conventionally classified as broad categories of case (yes disease) or control (no disease), which may result in misdiagnosis. A digital marker for coronary artery disease derived from machine learning and electronic health records can better quantify where an individual falls on the disease spectrum. Credit: Icahn School of Medicine at Mount Si
News | Heart Failure
Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...

Home December 22, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now